Abstract

Deseasin MCP-01 is a bacterial collagenolytic serine protease. Its catalytic domain alone can degrade collagen, and its C-terminal PKD domain is a collagen-binding domain (CBD) that can improve the collagenolytic efficiency of the catalytic domain by an unknown mechanism. Here, scanning electron microscopy (SEM), atomic force microscopy (AFM), zeta potential, and circular dichroism spectroscopy were used to clarify the functional mechanism of the PKD domain in MCP-01 collagenolysis. The PKD domain observably swelled insoluble collagen. Its collagen-swelling ability and its improvement to the collagenolysis of the catalytic domain are both temperature-dependent. SEM observation showed the PKD domain swelled collagen fascicles with an increase of their diameter from 5.3 mum to 8.8 mum after 1 h of treatment, and the fibrils forming the fascicles were dispersed. AFM observation directly showed that the PKD domain bound collagen, swelled the microfibrils, and exposed the monomers. The PKD mutant W36A neither bound collagen nor disturbed its structure. Zeta potential results demonstrated that PKD treatment increased the net positive charges of the collagen surface. PKD treatment caused no change in the content or the thermostability of the collagen triple helix. Furthermore, the PKD-treated collagen could not be degraded by gelatinase. Therefore, though the triple helix monomers were exposed, the PKD domain could not unwind the collagen triple helix. Our study reveals the functional mechanism of the PKD domain of the collagenolytic serine protease MCP-01 in collagen degradation, which is distinct from that of the CBDs of mammalian matrix metalloproteases.

Highlights

  • Deseasin MCP-01 is a bacterial collagenolytic serine protease

  • Our study reveals the functional mechanism of the polycystic kidney disease (PKD) domain of the collagenolytic serine protease MCP-01 in collagen degradation, which is distinct from that of the collagen-binding domain (CBD) of mammalian matrix metalloproteases

  • In this study, using the techniques of atomic force microscopy (AFM), circular dichroism (CD) spectroscopy, scanning electron microscopy (SEM), and zeta potential, we studied the changes in collagen caused by the binding of the PKD domain of deseasin MCP-01 to collagen to clarify the function of the PKD domain in MCP-01 collagenolysis

Read more

Summary

PKD Domain Swells but Does Not Unwind Collagen Triple Helix

Collagenolytic proteases include mammalian matrix metalloproteases (MMPs) and bacterial collagenases, consisting of collagenolytic metalloproteases and collagenolytic serine proteases. Most MMPs have a hemopexinlike C domain functioning as a CBD [15,16,17,18,19]; the collagenolytic metalloproteases ColG and ColH from Clostridium histolyticum both have CBDs [20]; and the collagenolytic serine protease from Geobacillus collagenovorans MO-1 has a collagen-binding segment [21]. The C-terminal PKD domain of the collagenolytic serine protease deseasin MCP-01 functions as a CBD [10]. Our previous study showed that the collagen binding of the PKD domain of deseasin MCP-01 improves the collagenolytic efficiency of its catalytic domain [10]. This suggests that, besides binding collagen, the PKD domain of deseasin MCP-01 may have some unknown function that helps MCP-01 digest collagen. We found that the PKD domain of MCP-01 did not unwind the collagen triple helix, but did swell collagen to expose the triple helix monomers, potentially facilitating their hydrolysis by the MCP-01 catalytic domain

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call